Phototrexate

From WikiMD.com Medical Encyclopedia

(Redirected from Cis-phototrexate)

A light-activated prodrug of methotrexate


Phototrexate is a prodrug of methotrexate, designed to be activated by light. It is part of a class of drugs known as photopharmacology, which involves the use of light to control the activity of pharmaceutical agents. This approach allows for spatial and temporal control of drug activation, potentially reducing side effects and increasing therapeutic efficacy.

Mechanism of Action[edit | edit source]

Phototrexate is an inactive form of methotrexate that becomes active upon exposure to specific wavelengths of light. Methotrexate itself is a well-known antimetabolite and antifolate drug that inhibits the enzyme dihydrofolate reductase (DHFR), leading to a decrease in tetrahydrofolate and subsequent inhibition of DNA synthesis, RNA synthesis, and protein synthesis. By using light to activate phototrexate, it is possible to target the drug's effects to specific tissues or cells, minimizing systemic exposure and reducing potential side effects.

Applications[edit | edit source]

Phototrexate is primarily being investigated for its potential use in treating cancer and autoimmune diseases. In cancer therapy, the ability to activate the drug in a localized area could allow for higher concentrations of the active drug in the tumor while sparing healthy tissues. In autoimmune diseases, such as rheumatoid arthritis, targeted activation could reduce the immunosuppressive effects on the entire body.

Advantages of Photopharmacology[edit | edit source]

The use of light to control drug activity offers several advantages:

  • Spatial Control: Drugs can be activated in specific locations, reducing off-target effects.
  • Temporal Control: Activation can be timed precisely, allowing for synchronization with biological rhythms or other treatments.
  • Reversibility: Some photopharmacological agents can be deactivated by light, providing an additional layer of control.

Challenges and Considerations[edit | edit source]

While photopharmacology offers promising advantages, there are challenges to its implementation:

  • Light Penetration: The effectiveness of light activation depends on the ability of light to penetrate tissues, which can be limited in deeper tissues.
  • Safety: The safety of repeated light exposure and the potential for unintended activation must be considered.
  • Delivery Systems: Effective delivery systems are needed to ensure that the prodrug reaches the target tissue before activation.

Future Directions[edit | edit source]

Research is ongoing to improve the efficacy and safety of phototrexate and other photopharmacological agents. Advances in light delivery systems, such as optical fibers and biocompatible light sources, are being explored to enhance the clinical applicability of these therapies.

Related Pages[edit | edit source]

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD